EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Disrupting glioblastoma networks with tumor treating fields (TTFields) in in vitro models

Steffen Schlieper-Scherf, Nils Hebach, David Hausmann, Daniel D Azorín, Dirk C Hoffmann, Sandra Horschitz, Elena Maier, Phillip Koch, Matthia A Karreman, Nima Etminan, Miriam Ratliff

Journal of Neuro-Oncology · 2024

DOI: 10.1007/s11060-024-04786-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuro-Oncology, 2024. Verfasst von Steffen Schlieper-Scherf und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Bundesministerium für Bildung und Forschung (BMBF), Olympia-Morata Scholarship/University of Heidelberg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study investigates the biological effect of Tumor Treating Fields (TTFields) on key drivers of glioblastoma’s malignancy—tumor microtube (TM) formation—and on the function and overall integrity of the tumor cell network.

Method

Using a two-dimensional monoculture GB cell network model (2DTM) of primary glioblastoma cell (GBC) cultures (S24, BG5 or T269), we evaluated the effects of TTFields on cell density, interconnectivity and structural integrity of the tumor network. We also analyzed calcium (Ca 2+ ) transient dynamics and network morphology, validating findings in patient-derived tumoroids and brain tumor organoids.

Results

In the 2DTM assay, TTFields reduced cell density by 85–88% and disrupted network interconnectivity, particularly in cells with multiple TMs. A “crooked TM” phenotype emerged in 5–6% of treated cells, rarely seen in controls. Ca 2+ transients were significantly compromised, with global Ca 2+ activity reduced by 51–83%, active and periodic cells by over 50%, and intercellular co-activity by 52% in S24, and almost completely in BG5 GBCs. The effects were more pronounced at 200 kHz compared to a 50 kHz TTFields. Similar reductions in Ca 2+ activity were observed in patient-derived tumoroids. In brain tumor organoids, TTFields significantly reduced tumor cell proliferation and infiltration.

Conclusion

Our comprehensive study provides new insights into the multiple effects of Inovitro-modeled TTFields on glioma progression, morphology and network dynamics in vitro. Future in vivo studies to verify our in vitro findings may provide the basis for a deeper understanding and optimization of TTFields as a therapeutic modality in the treatment of GB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsHumansCalciumTumor Cells, CulturedOrganoidsCell Line, TumorElectric Stimulation TherapyCell Proliferation

Stichwörter der Autor:innen

Cancer cell networkCancer neuroscienceGliomaTTFieldsTumor microtubes

Substanzen

Calcium

Autor:innen und Institutionen

  • Department of Neurosurgery, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany.
  • Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Central Institute of Mental Health, University of Heidelberg/Medical Faculty Mannheim, Mannheim, Germany.
  • Hector Institute for Translational Brain Research (HITBR gGmbH), Mannheim, Germany.
  • Department of Neurosurgery, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany. miriam.ratliff@umm.de.

Förderung

  • Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
  • Bundesministerium für Bildung und Forschung (BMBF)
  • Olympia-Morata Scholarship/University of Heidelberg
  • Medizinische Fakultät Mannheim der Universität Heidelberg

Zitieren

APA

Schlieper-Scherf, S., Hebach, N., Hausmann, D., Azorín, D. D., Hoffmann, D. C., Horschitz, S., Maier, E., Koch, P., Karreman, M. A., Etminan, N., & Ratliff, M. (2024). Disrupting glioblastoma networks with tumor treating fields (TTFields) in in vitro models. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04786-0

Vancouver

Schlieper-Scherf S, Hebach N, Hausmann D, Azorín DD, Hoffmann DC, Horschitz S, et al. Disrupting glioblastoma networks with tumor treating fields (TTFields) in in vitro models. Journal of Neuro-Oncology. 2024. doi:10.1007/s11060-024-04786-0

BibTeX
@article{SchlieperScherf2024,
  author = {Schlieper-Scherf, Steffen and Hebach, Nils and Hausmann, David and Azorín, Daniel D and Hoffmann, Dirk C and Horschitz, Sandra and Maier, Elena and Koch, Phillip and Karreman, Matthia A and Etminan, Nima and Ratliff, Miriam},
  title = {Disrupting glioblastoma networks with tumor treating fields (TTFields) in in vitro models},
  journal = {Journal of Neuro-Oncology},
  year = {2024},
  doi = {10.1007/s11060-024-04786-0}
}
Kostenlos starten →